Skip to content

Dr Emmanuelle Papleux

Active
Private limited companyfounded 2022active for 4 yearsCarembergstraat(P.E.) 147, 7850 Enghien, BelgiumKBO/BCE: BE 0787.741.552
Summary

Dr Emmanuelle Papleux has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €248,777 and a net result of €86,861. Equity has been growing by about 32% per year since 2022. Its solvency ranks better than 52% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-06-2022 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.333.075.672 1070 Anderlecht, since 28-06-2022
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€147,690
▼ 7.7%
Turnover
≈ €280,000
estimated
Profit
€86,861
▼ 12.0%
Equity
€248,777
▼ 1.2%
Total assets
€380,037
▲ 18.1%
  • 2025 accounts filed 81 days after the deadline
Score breakdownraises riskLast filed accounts filed 81 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.95, cash €117,029Equity €248,777 (65.5% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 90-10
equity 65.5% of total assets
Liquidity 76-1
short-term debt 29.4% · cash 30.8%
Profitability 97-3
return on assets 22.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.1%highest value 01-2025: 0.1%● unchanged vs 12-2024highest value 02-2025: 0.1%● unchanged vs 01-2025highest value 03-2025: < 0.1%▼ -0.1 percentage points vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €23,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.95 (4.14 in 2024), above the usual 1.5. Short-term debt is 29.4% and cash 30.8% of total assets. 34.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 53% of them on solvency, 58% on liquidity, 57% on profitability and 33% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 81 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Liquidity: current ratio 1.95, cash €117,029
NBB · annual accounts
lowers risk · Equity €248,777 (65.5% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 81 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-10-2026, 81 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filings
Deviation from the deadline
2025
81 days late
2024
28 days late
2023
26 days late
2022
24 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 28 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (3 of the last 4 accounts filed within 52 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Recent changes

  1. · Gazette deed Registered office moved from Anderlecht to Petit Enghien
  2. · Gazette deed IncorporationStarting capital €5,000 · Appointment: PAPLEUX Emmanuelle Anne Marie Yves Line (director)
All 11 events

Comparable companies

These companies have the same main activity as Dr Emmanuelle Papleux: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €343,000 and €402,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
Dr Emmanuelle Papleux Enghien€380,037€147,690
BE PSY MED Colfontaine€358,659€140,092
DOCTEUR VALET MPR Charleroi€372,558€166,569
Cabinet Médical du Docteur WILLEME SRL Liège€384,560€146,204
Dr. Stijn Therssen, Oftalmoloog Scherpenheuvel-Zichem€402,241€141,098
Levexia Antwerpen€357,960€156,267
Dr. Anouk Serrien - Neurologie Merchtem€342,742€147,789
Full comparison

Key facts about Dr Emmanuelle Papleux

What is the company number of Dr Emmanuelle Papleux?
The company number of Dr Emmanuelle Papleux is 0787.741.552. The VAT number is the same number with BE in front: BE 0787.741.552.
Where is Dr Emmanuelle Papleux based?
The registered office is at Carembergstraat(P.E.) 147, 7850 Enghien.Company details
What does Dr Emmanuelle Papleux do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr Emmanuelle Papleux?
The legal form of Dr Emmanuelle Papleux is Private limited company (BV).
When was Dr Emmanuelle Papleux founded?
Dr Emmanuelle Papleux was founded on 28-06-2022.
Is Dr Emmanuelle Papleux still active?
Yes, Dr Emmanuelle Papleux is an active enterprise in the KBO register.
What is the turnover of Dr Emmanuelle Papleux?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €147,690 and 43 comparable companies (NACE 86220). It probably lies between €230,000 and €370,000.Financials
Is Dr Emmanuelle Papleux profitable?
In financial year 2025, Dr Emmanuelle Papleux made a profit of €86,861.
Where can I find the annual accounts of Dr Emmanuelle Papleux?
Dr Emmanuelle Papleux filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr Emmanuelle Papleux due?
Dr Emmanuelle Papleux must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.